(Q36429503)

14 August 2017

1 reference

title

Anti-thrombotics in thrombosis and cancer (English)

1 reference

14 August 2017

0 references

Shaker A Mousa

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

395-403

1 reference

Anticoagulants in thrombosis and cancer: the missing link

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Steps in tumor metastasis: new concepts from intravital videomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Anticoagulants as anticancer agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Mechanisms of hypercoagulation in malignancy and during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Platelet-endothelial interaction in tumor angiogenesis and microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Fibrin as a component of the tumor stroma: origins and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Actions of heparin that may affect the malignant process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Angiogenesis inhibitors: current & future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Antimetastatic effect of tinzaparin, a low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Pathophysiology of the thrombophilic state in the cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Pathways of coagulation/fibrinolysis activation in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Epidemiology of thrombosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31-->q33 by in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Prognosis of Cancers Associated with Venous Thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

Venous thromboembolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.395

21 January 2018

Identifiers

DOI

10.1517/14796694.1.3.395

1 reference

14 August 2017

1 reference